Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide
- PMID: 11874828
- PMCID: PMC1754044
- DOI: 10.1136/ard.61.4.290
Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide
Abstract
Background: Effective treatment of active rheumatoid arthritis (RA) requires early diagnosis and early disease modifying antirheumatic drug (DMARD) treatment to have an impact on long term morbidity and mortality. Clinical criteria would facilitate early referral of the patient with suspected RA to a rheumatologist for definitive diagnosis and initiation of DMARD treatment at that point in the disease most likely to have an impact on the long term outcome.
Objective: To develop a referral recommendation that may serve as a clinical guide for primary care doctors, enabling them to identify patients with suspected RA during the early inflammatory stages.
Methods: Key points of the referral criteria were formed based on a thorough literature review targeting early RA, early arthritis clinics, DMARD treatment for early RA, prognostic factors of disease progression, early RA clinical trials, and quality of life. Evidence was graded using the methods defined by Shekelle et al. A draft version of the criterion was circulated among the authors for critical evaluation. A consensus integrated these comments.
Results: Clinical evidence strongly supports the observations that structural damage occurs early in active RA and that early DMARD treatment improves the long term outcome of the disease. The observations indicate that rapid referral to a rheumatologist is advised when RA is suspected. This may be supported by the presence of any of the following: >or=3 swollen joints, metatarsophalangeal/metacarpophalangeal involvement, and morning stiffness of >or=30 minutes.
Conclusion: The proposed early referral recommendation is a viable tool for primary care doctors to identify potential patients with active RA early in the disease. Early referral to a rheumatologist for definitive diagnosis and early DMARD treatment should improve the long term outcome of RA.
Figures
Similar articles
-
Long-term impact of delay in assessment of patients with early arthritis.Arthritis Rheum. 2010 Dec;62(12):3537-46. doi: 10.1002/art.27692. Arthritis Rheum. 2010. PMID: 20722031
-
Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.J Rheumatol. 2012 Apr;39(4):707-11. doi: 10.3899/jrheum.110818. Epub 2012 Feb 15. J Rheumatol. 2012. PMID: 22337235
-
Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.Ann Rheum Dis. 2002 Jul;61(7):630-4. doi: 10.1136/ard.61.7.630. Ann Rheum Dis. 2002. PMID: 12079906 Free PMC article.
-
Rheumatoid Arthritis.Ann Intern Med. 2019 Jan 1;170(1):ITC1-ITC16. doi: 10.7326/AITC201901010. Ann Intern Med. 2019. PMID: 30596879 Review.
-
Early rheumatoid arthritis -- is there a window of opportunity?J Rheumatol Suppl. 2007 Nov;80:1-7. J Rheumatol Suppl. 2007. PMID: 17985417 Review.
Cited by
-
Challenges faced in Latin America for the implementation of an ideal health-care model for rheumatoid arthritis patients: are we ready?Clin Rheumatol. 2015 Mar;34 Suppl 1(Suppl 1):S79-93. doi: 10.1007/s10067-015-3034-7. Epub 2015 Aug 9. Clin Rheumatol. 2015. PMID: 26255188 Free PMC article. Review.
-
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?Arthritis Res Ther. 2008;10(3):208. doi: 10.1186/ar2418. Epub 2008 May 29. Arthritis Res Ther. 2008. PMID: 18557991 Free PMC article. Review.
-
Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity.Clin Rheumatol. 2017 Nov;36(11):2607-2612. doi: 10.1007/s10067-017-3791-6. Epub 2017 Aug 19. Clin Rheumatol. 2017. PMID: 28823077
-
Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.Arthritis Res Ther. 2012 Nov 19;14(6):R249. doi: 10.1186/ar4092. Arthritis Res Ther. 2012. PMID: 23164197 Free PMC article.
-
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Arthritis Res Ther. 2011 Apr 28;13(2):215. doi: 10.1186/ar3280. Arthritis Res Ther. 2011. PMID: 21539724 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical